We are live on
!
Find out more
NC
nVerses Capital Portfolio holdings
AUM
$65M
This Fund
S&P 500
This Quarter
Est. Return
-0.85%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$110M
AUM Growth
+$65.4M
(+146%)
Cap. Flow
+$71.8M
Cap. Flow
% of AUM
65.23%
Top 10 Holdings %
Top 10 Hldgs %
6.91%
Holding
496
New
297
Increased
33
Reduced
18
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jefferies Financial Group
JEF
|
+$942K |
| 2 |
Cintas
CTAS
|
+$881K |
| 3 |
Stryker
SYK
|
+$822K |
| 4 |
Ally Financial
ALLY
|
+$820K |
| 5 |
Blue Owl Capital
OBDC
|
+$812K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Expedia Group
EXPE
|
+$436K |
| 2 |
NetApp
NTAP
|
+$435K |
| 3 |
Sherwin-Williams
SHW
|
+$421K |
| 4 |
Aurinia Pharmaceuticals
AUPH
|
+$406K |
| 5 |
Alignment Healthcare
ALHC
|
+$396K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.9% |
| 2 | Industrials | 16.1% |
| 3 | Technology | 15.4% |
| 4 | Healthcare | 14.27% |
| 5 | Consumer Discretionary | 14.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
TMC The Metals Company
TMC
$1.98B
| $95.9K | 0.09% |
+20,534
| New | +$132K |
|
327
Runway Growth Finance
RWAY
$287M
| $95.7K | 0.09% |
13,937
-26,926
| -66% | -$224K |
|
328
4D Molecular Therapeutics
FDMT
$562M
| $93.7K | 0.09% |
+10,069
| New | +$87.6K |
|
329
CryoPort
CYRX
$762M
| $83.5K | 0.08% |
+10,084
| New | +$91.1K |
|
330
Iovance Biotherapeutics
IOVA
$2.87B
| $82.2K | 0.07% |
+23,420
| New | +$74.9K |
|
331
Camping World
CWH
$653M
| $77K | 0.07% |
+11,276
| New | +$116K |
|
332
RPC Inc
RES
$1.3B
| $74K | 0.07% |
10,453
-34,942
| -77% | -$218K |
|
333
Gogo Inc
GOGO
$492M
| $72.3K | 0.07% |
17,984
+5,763
| +47% | +$26.3K |
|
334
Black Diamond Therapeutics
BDTX
$112M
| $66.9K | 0.06% |
31,411
+20,689
| +193% | +$49.2K |
|
335
Annexon
ANNX
$886M
| $65.9K | 0.06% |
+11,897
| New | +$67K |
|
336
Priority Technology Holdings
PRTH
$444M
| $65.8K | 0.06% |
+13,945
| New | +$76.4K |
|
337
Larimar Therapeutics
LRMR
$432M
| $58.5K | 0.05% |
+13,004
| New | +$52K |
|
|
GRSD
338
Grandstand Limited Ordinary Shares
GRSD
$67M
| $56.7K | 0.05% |
+14,606
| New | +$65.5K |
|
339
ChargePoint
CHPT
$161M
| $51.7K | 0.05% |
+10,646
| New | +$64.8K |
|
340
Voyager Therapeutics
VYGR
$201M
| $48.8K | 0.04% |
+12,631
| New | +$49.7K |
|
341
BlackRock TCP Capital
TCPC
$345M
| $42K | 0.04% |
+11,638
| New | +$54K |
|
342
Achieve Life Sciences
ACHV
$683M
| $41.7K | 0.04% |
+14,195
| New | +$63K |
|
|
KLC
343
KinderCare Learning Companies
KLC
$612M
| $38.7K | 0.04% |
+17,613
| New | +$66.3K |
|
344
Lifecore Biomedical
LFCR
$190M
| $37.3K | 0.03% |
+10,027
| New | +$69.2K |
|
345
EVgo
EVGO
$229M
| $34.1K | 0.03% |
+19,810
| New | +$53K |
|
|
AIRJ
346
Montana Technologies Corp
AIRJ
$429M
| $34K | 0.03% |
+13,535
| New | +$45.6K |
|
347
Richtech Robotics
RR
$360M
| $28K | 0.03% |
+13,416
| New | +$41.2K |
|
348
Veritone
VERI
$122M
| $27.4K | 0.02% |
+13,900
| New | +$47K |
|
349
AbCellera Biologics
ABCL
$2.12B
| – | – |
-35,446
| Closed | -$121K |
|
350
Abbott
ABT
$187B
| – | – |
-2,187
| Closed | -$274K |
|
Similar funds
PFO
NIP
CPM
HFCII
1M
CMU
EVC
LC
nVerses Capital's Q1 2026 Portfolio in Review
As of Q1 2026, nVerses Capital held 496 positions worth $110M, up 146% from $44.6M the previous quarter. Its ten largest holdings account for 6.9% of the portfolio.
nVerses Capital deployed $71.8M of net new capital in Q1 2026, opening 297 new positions and adding to 33 existing holdings. Its largest new stake was Jefferies Financial Group: 18,158 shares worth $749K.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Runway Growth Finance, an estimated $224K trimmed.
- nVerses Capital's largest Q1 2026 buy was Jefferies Financial Group: 18,158 shares worth $749K.
- nVerses Capital added most to Intuitive Surgical in Q1 2026, an estimated $614K increase.
- nVerses Capital's biggest Q1 2026 reduction was Runway Growth Finance, cutting an estimated $224K.
- nVerses Capital fully exited Expedia Group in Q1 2026, selling an estimated $436K.
- nVerses Capital's ten largest holdings make up 6.9% of its $110M portfolio in Q1 2026.
- nVerses Capital opened 297 new positions and closed 148 in Q1 2026.
- nVerses Capital's portfolio value rose 146% quarter-over-quarter to $110M.
Based on nVerses Capital's 13F filing for Q1 2026, filed 13 May 2026.